Time trends in intracranial bleeding associated with direct oral anticoagulants: a 5-year cohort study
K Hogg, B Bahl, M Latrous, SS Argentina… - … Open Access Journal, 2015 - cmajopen.ca
Background: Over the past 5 years, dabigatran, rivaroxaban and apixaban were approved
for stroke prevention. Phase III studies have shown a lower risk of intracranial bleeding with …
for stroke prevention. Phase III studies have shown a lower risk of intracranial bleeding with …
The role of steroid hormones, GREB1, and reproductive status in ovarian cancer progression
K Hodgkinson - 2016 - ruor.uottawa.ca
… Bojana Djordjevic (histology analysis), Rose Vuong (ChIP experiment), Pascale Charette
(angiogenesis data), Sarina Scaffidi Argentina (GREB1 induction by E2 in human cell lines), …
(angiogenesis data), Sarina Scaffidi Argentina (GREB1 induction by E2 in human cell lines), …
[BOOK][B] Investigating the therapeutic efficacy of a novel inhibitor GAP-107B8 on ovarian cancer cells
FJ Yan - 2011 - search.proquest.com
Ovarian cancers often develop resistance mechanisms against the standard platinum and
taxane chemotherapy, which indicates the need for novel therapeutics to improve patient …
taxane chemotherapy, which indicates the need for novel therapeutics to improve patient …